Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL853782 | 0.91 | HSD17B2 (0.49) | MAPTKMT2ASMN1; SMN2MEN1HSD17B2 | |
| SCHEMBL15390848 | 0.89 | CA12 (0.50) | MAPTSMN1; SMN2TSHRALDH1A1KDM4E | |
| SCHEMBL15305553 | 0.83 | EPHX1 (0.44) | MAPTKMT2ASMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL6122016 | 0.82 | PYCR1 (0.43) | MAPTKMT2ASMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL8251185 | 0.81 | MAPT (0.54) | MAPTKMT2ASMN1; SMN2MEN1HSD17B2 | |
| SCHEMBL20212292 | 0.81 | ALDH1A1 (0.56) | MAPTKMT2ASMN1; SMN2MEN1HSD17B2 | |
| SCHEMBL30036817 | 0.81 | ALDH1A1 (0.56) | MAPTKMT2ASMN1; SMN2MEN1HSD17B2 | |
| SCHEMBL8732462 | 0.80 | MAPT (0.53) | MAPTKMT2ASMN1; SMN2MEN1HSD17B2 | |
| SCHEMBL31295843 | 0.79 | ACACB (0.39) | MAPTKMT2AMEN1ALDH1A1 | |
| SCHEMBL27942554 | 0.79 | MTNR1A (0.51) | KMT2AMEN1TSHRALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12077510-B2 | Carboxylic acid compounds | Sumitomo Pharma Co., Ltd. (JP) | 2024-09-03 | — | — | US | disclosed |
| US-20220267282-A1 | CARBOXYLIC ACID COMPOUNDS | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2022-08-25 | — | — | US | disclosed |
| US-11299465-B2 | Carboxylic acid compounds | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2022-04-12 | — | — | US | disclosed |
| US-20200317623-A1 | CARBOXYLIC ACID COMPOUNDS | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2020-10-08 | — | — | US | disclosed |
| US-10562861-B2 | Carboxylic acid compounds | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2020-02-18 | — | — | US | disclosed |
| US-20190119220-A1 | CARBOXYLIC ACID COMPOUNDS | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2019-04-25 | — | — | US | disclosed |
| US-10150743-B2 | Carboxylic acid compounds | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2018-12-11 | — | — | US | disclosed |
| EP-2850067-B1 | CARBOXYLIC ACID COMPOUNDS | SUMITOMO DAINIPPON PHARMA CO LTD (JP) | 2017-08-16 | — | — | EP | disclosed |
| US-20160251319-A1 | CARBOXYLIC ACID COMPOUNDS | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2016-09-01 | — | — | US | disclosed |
| US-9376398-B2 | Carboxylic acid compounds | SUMITOMO DAINIPPON PHARMA CO., LTD (JP) | 2016-06-28 | — | — | US | disclosed |
| US-20150099770-A1 | CARBOXYLIC ACID COMPOUNDS | Sumitomo Pharma Co., Ltd. (JP) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099770-A1 | CARBOXYLIC ACID COMPOUNDS | C9, SUCNR1, C3AR1 | MAPT 4427/4885KMT2A 2031/4885SMN1; SMN2 1872/4885 |
| US-20160251319-A1 | CARBOXYLIC ACID COMPOUNDS | C9, SUCNR1, C3AR1 | MAPT 4427/4885KMT2A 2031/4885SMN1; SMN2 1872/4885 |
| US-10150743-B2 | Carboxylic acid compounds | C9, C3AR1, SUCNR1 | MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885 |
| US-12077510-B2 | Carboxylic acid compounds | C9, C3AR1, SUCNR1 | MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885 |
| US-20200317623-A1 | CARBOXYLIC ACID COMPOUNDS | C9, C3AR1, SUCNR1 | MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885 |
| US-20190119220-A1 | CARBOXYLIC ACID COMPOUNDS | C9, C3AR1, SUCNR1 | MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885 |
| US-11299465-B2 | Carboxylic acid compounds | C9, C3AR1, SUCNR1 | MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885 |
| US-20220267282-A1 | CARBOXYLIC ACID COMPOUNDS | C9, C3AR1, SUCNR1 | MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885 |
| US-10562861-B2 | Carboxylic acid compounds | C9, C3AR1, SUCNR1 | MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.